Page last updated: 2024-09-03

zk 112993 and methionine

zk 112993 has been researched along with methionine in 1 studies

Compound Research Comparison

Studies (zk 112993)	Trials (zk 112993)	Recent Studies (post-2010) (zk 112993)	Studies (methionine)	Trials (methionine)	Recent Studies (post-2010) (methionine)
25	0	0	27,485	530	5,020

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baker, C; Hawkins, P; Norris, B; Quinn, PG; Sheridan, PL; Wei, LL	1

Other Studies

1 other study(ies) available for zk 112993 and methionine

Article	Year
An amino-terminal truncated progesterone receptor isoform, PRc, enhances progestin-induced transcriptional activity. Molecular endocrinology (Baltimore, Md.), 1996, Volume: 10, Issue:11 Topics: Antineoplastic Agents; Breast Neoplasms; Enhancer Elements, Genetic; Gonanes; HeLa Cells; Hormone Antagonists; Humans; Methionine; Mifepristone; Progesterone Congeners; Progestins; Promegestone; Protein Biosynthesis; Receptors, Progesterone; Transcription, Genetic; Transfection; Tumor Cells, Cultured	1996

Article

Year

An amino-terminal truncated progesterone receptor isoform, PRc, enhances progestin-induced transcriptional activity.

Molecular endocrinology (Baltimore, Md.), 1996, Volume: 10, Issue:11

Topics: Antineoplastic Agents; Breast Neoplasms; Enhancer Elements, Genetic; Gonanes; HeLa Cells; Hormone Antagonists; Humans; Methionine; Mifepristone; Progesterone Congeners; Progestins; Promegestone; Protein Biosynthesis; Receptors, Progesterone; Transcription, Genetic; Transfection; Tumor Cells, Cultured

1996